Antitrust concerns and the FDA approval process : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017.

Bibliographic Details
Corporate Author: United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law (Author)
Language:English
Published: Washington : U.S. Government Publishing Office, 2018.
Subjects:
Genre:
Online Access:
Physical Description:1 online resource (iv, 51 pages)
Variant Title:
Antitrust concerns and the Food and Drug Administration approval process
Format: Government Document Electronic eBook

MARC

LEADER 00000cam a2200000 i 4500
001 in00005868590
003 OCoLC
005 20220616022752.0
006 m o d f
007 cr bn||||a||||
008 180627s2018 dcu o f000 0 eng c
035 |a (OCoLC)1042073861 
040 |a GPO  |b eng  |e rda  |e pn  |c GPO  |d GPO  |d MERUC  |d OCLCF  |d INT  |d OCLCQ  |d OCLCO  |d GPO  |d MvI  |d UtOrBLW 
042 |a pcc 
043 |a n-us--- 
049 |a EEXU 
074 |a 1020-C (online) 
086 0 |a Y 4.J 89/1:115-27 
088 |a Serial no. 115-27 (United States. Congress. House. Committee on the Judiciary) 
099 |a Y 4.J 89/1:115-27 Online 
110 1 |a United States.  |b Congress.  |b House.  |b Committee on the Judiciary.  |b Subcommittee on Regulatory Reform, Commercial and Antitrust Law,  |e author.  |0 http://id.loc.gov/authorities/names/no2013088204 
245 1 0 |a Antitrust concerns and the FDA approval process :  |b hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017. 
246 3 |a Antitrust concerns and the Food and Drug Administration approval process 
264 1 |a Washington :  |b U.S. Government Publishing Office,  |c 2018. 
300 |a 1 online resource (iv, 51 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
500 |a "Serial number 115-27." 
588 0 |a Online resource; title from PDF title screens (govinfo web site, viewed on June 27, 2018). 
610 1 0 |a United States.  |b Food and Drug Administration  |v Rules and practice.  |0 http://id.loc.gov/authorities/names/n80126147 
650 0 |a Drugs  |z United States  |x Testing.  |0 http://id.loc.gov/authorities/subjects/sh2009123883 
650 0 |a Drug approval  |z United States.  |0 http://id.loc.gov/authorities/subjects/sh2009123884 
650 0 |a Drugs  |x Safety regulations  |z United States.  |0 http://id.loc.gov/authorities/subjects/sh85039719 
650 0 |a Medical instruments and apparatus  |x Safety regulations  |z United States.  |0 http://id.loc.gov/authorities/subjects/sh2008107639 
650 0 |a Generic drugs  |z United States.  |0 http://id.loc.gov/authorities/subjects/sh2009125738 
650 0 |a Competition  |z United States.  |0 http://id.loc.gov/authorities/subjects/sh2008100014 
650 0 |a Antitrust law  |z United States.  |0 http://id.loc.gov/authorities/subjects/sh2007100529 
610 1 7 |a United States.  |b Food and Drug Administration.  |2 fast  |0 (OCoLC)fst00549734 
650 7 |a Antitrust law.  |2 fast  |0 (OCoLC)fst00810849 
650 7 |a Competition.  |2 fast  |0 (OCoLC)fst00871464 
650 7 |a Drug approval.  |2 fast  |0 (OCoLC)fst00898661 
650 7 |a Drugs  |x Safety regulations.  |2 fast  |0 (OCoLC)fst00898910 
650 7 |a Drugs  |x Testing.  |2 fast  |0 (OCoLC)fst00898940 
650 7 |a Generic drugs.  |2 fast  |0 (OCoLC)fst00939969 
650 7 |a Medical instruments and apparatus  |x Safety regulations.  |2 fast  |0 (OCoLC)fst01014229 
651 7 |a United States.  |2 fast  |0 (OCoLC)fst01204155 
776 0 8 |i Print version:  |a United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law.  |t Antitrust concerns and the FDA approval process  |w (OCoLC)1042073889 
776 0 8 |i Microfiche version:  |a United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law.  |t Antitrust concerns and the FDA approval process  |w (OCoLC)1078924440 
856 4 0 |z Connect to online resource - All users  |u https://purl.fdlp.gov/GPO/gpo93483  |t 0 
907 |y .b128544089  |b 211203  |c 180803 
998 |a (3)7f  |a (2)gd  |a 7e  |a wb  |b 190405  |c m  |d a   |e -  |f eng  |g dcu  |h 0  |i 5 
999 f f |i 1fe7b287-6f1a-558a-9413-539fe63142d5  |s d5286b4c-6294-5646-9ca6-f4cbf615b73c  |t 0 
952 f f |p Non-Circulating  |a Michigan State University-Library of Michigan  |b Michigan State University  |c MSU Online Resource  |d MSU Government Documents Online Resource  |t 0  |e Y 4.J 89/1:115-27 Online  |h Other scheme  |i Electronic Resource  |n 1 
856 4 0 |t 0  |u https://purl.fdlp.gov/GPO/gpo93483  |y Connect to online resource - All users 
856 4 0 |t 0  |u https://purl.fdlp.gov/GPO/gpo93483  |y Connect to online resource - All users